Introduction
CRISPR-Cas systems are adaptive immune systems found in 40% of bacteria and 90% of archaea. The hallmark of CRISPR-Cas systems is the CRISPR array, which is composed of alternating multiple, short, identical "repeat" sequences, interspersed with short, variable "spacer" sequences. A critical step in CRISPR immunity is biogenesis, (1) which involves transcription of a CRISPR array into a single, long precursor RNA that is then processed into individual CRISPR RNAs (crRNAs), with each crRNA containing a single spacer sequence. crRNAs associate with an effector Cas protein or Cas protein complex, and direct the Cas protein(s) to an invading nucleic acid sequence that is complementary to the crRNA spacer and includes a neighboring Protospacer Adjacent Motif (PAM). This leads to cleavage of the invading nucleic acid by a Cas protein nuclease, in a process known as "interference". Rho is a broadly conserved bacterial transcription termination factor. Rho terminates transcription only when nascent RNA is untranslated (2) . Hence, the primary function of Rho is to suppress the transcription of spurious, non-coding RNAs that initiate as a result of pervasive transcription (3) (4) (5) . To terminate transcription, Rho must load onto nascent RNA at a "Rho utilization site" (Rut). The precise sequence and structure requirements for Rho loading are not fully understood, but Ruts typically have a high C:G ratio, limited secondary structure, and are enriched in YC dinucleotides (2, 6) . However, the overall sequence/structure specificity of Ruts is believed to be low, and a large proportion of the Salmonella Typhimurium genome is predicted to be capable of functioning as a Rut (6) . Once Rho loads onto nascent RNA, it translocates along the RNA in a 5' to 3' direction using its helicase activity. Rho typically catches the RNA polymerase (RNAP) within 60-90 nucleotides, leading to transcription termination (2) . The ability of Rho to terminate untranslated RNA with relatively low specificity effectively limits the potential length of bacterial non-coding RNAs. However, there are two classes of bacterial non-coding RNA that are notably long: ribosomal RNA (rRNA) and CRISPR array transcripts. rRNA is resistant to Rho termination, likely due to redundant mechanisms (7) . The best-studied mechanism for preventing Rho termination involves the Nus factor complex, which is known to be associated with rRNA. The Nus complex consists of five proteins, NusA, NusB, NusE (ribosomal protein S10), NusG and SuhB, that bind to both nascent RNA and elongating RNAP. Nus complex formation begins with association of NusB/E with a short RNA sequence known as "BoxA". NusE has been proposed to interact with NusG (8) , which is associated with elongating RNAP, thus creating a loop in the nascent RNA (7, 9) . The Nus complex prevents Rho termination (10, 11) in a BoxA-dependent manner (11) (12) (13) , and BoxA elements are found in phylogenetically diverse copies of rRNA (14, 15) .
Results and Discussion
We identified boxA-like sequences a short distance upstream of both CRISPR arrays (CRISPR-I and CRISPR-II) in S. Typhimurium (Fig. 1A) . To facilitate studies of the S. Typhimurium CRISPR-Cas system, which is transcriptionally silenced by H-NS (16), we introduced a strong, constitutive promoter (17) in place of cas3 (Fig. 1A) . This promoter drives transcription of the cas8e-cse2-cas7-cas5-cas6e-cas1-cas2 operon, and our ChIP-qPCR data for RNAP indicate that transcription continues through the boxA into the CRISPR array (Fig. S1) . We also introduced a strong, constitutive promoter upstream of the CRISPR-II array, immediately downstream of the queE gene (Fig. 1A) . Transcription from this promoter also covers the putative boxA. To determine whether the putative boxA elements upstream of the CRISPR arrays are genuine, we measured association of TAP-tagged SuhB with elongating RNAP at the CRISPR-II array using ChIP-qPCR, which likely detects indirect association of Typhimurium. Repeat sequences are represented by gray rectangles and spacer sequences are represented by black squares. Spacers are numbered within the array, with spacer 1 being closest to the leader sequence (dashed rectangle). The CRISPR-I array is co-transcribed with the upstream cas genes. For the work presented in this study, the cas3 gene was deleted and replaced with a constitutive promoter. Similarly, a constitutive promoter was inserted immediately downstream of queE, upstream of the CRISPR-II array. boxA elements (boxes containing an "A") are located immediately upstream of the leader sequences of both CRISPR arrays. (B) Relative occupancy of SuhB-TAP, determined by ChIP-qPCR, within the highly expressed rpsA gene (gray bars), or at the boxA sequence upstream of CRISPR-II (black bars). Occupancy was measured in a strain with an intact boxA upstream of CRISPR-II (AMD710), or a single base-pair substitution within the boxA (AMD711). Values plotted are the average of three independent biological replicates. Error bars represent one standard-deviation from the mean.
SuhB with the DNA (7). Our data indicate robust association of SuhB with the region immediately downstream of the putative boxA, but not with the highly transcribed rpsA gene that is not associated with a boxA (Fig. 1B) . By contrast, we detected substantially reduced SuhB association with the same genomic region in a strain containing a single base pair substitution in the boxA that is expected to abrogate NusB/E association (18) (19) (20) , with SuhB association being similar to that with rpsA. The level of SuhB association with rpsA was not significantly altered by the mutation in the CRISPR-II boxA. We conclude that the CRISPR-II array transcript includes a functional upstream BoxA. For almost 40 years, the Nus factor complex was believed to be a dedicated rRNA regulator, with no other known bacterial targets (14) . We recently identified a novel function for the Nus factor complex -autoregulation of suhB -and we provided evidence for many additional targets (18) . Nonetheless, identification of CRISPR arrays as a novel target for the Nus factor complex substantially increases the number of known targets and provides new opportunities for investigating the mechanism by which Nus factors prevent Rho termination.
We hypothesized that BoxA-mediated association of the Nus factor complex with RNAP at the S. Typhimurium CRISPR arrays prevents premature Rho-dependent transcription termination. To test this hypothesis, we constructed lacZ transcriptional reporter fusions that contain a constitutive pro- Enriched sequence motifs in Cas5-bound regions, as identified by MEME (30) . Sequence matches to the AWG PAM and to the seed sequence of specific spacers are indicated. The number of Cascade-bound genomic regions containing each sequence motif is indicated, as is the enrichment score (E) generated by MEME (30).
moter followed by the sequence downstream of the queE gene (upstream of the CRISPR-II array), extending to either the 2nd ("short fusion") or the 11th ("long fusion") spacer of the array ( Fig. 2A) . We constructed equivalent fusions that contain a single base pair substitution in the boxA that is expected to abrogate NusB/E association (Fig. 1B ) (18) (19) (20) . We then measured β-galactosidase activity for each of the four fusions in cells grown with/without bicyclomycin (BCM), a specific inhibitor of Rho (2). In the absence of BCM, expression of the long fusion but not the short fusion was substantially reduced by mutation of the boxA (Fig. 2B) . By contrast, expression of all fusions was similar for cells grown in the presence of BCM (Fig. 2B) . Thus, our data are consistent with BoxA-mediated, Nus factor anti-termination of the CRISPR array, with Rho termination occurring between the 2nd and 11th spacer when anti-termination is disrupted. Surprisingly, expression levels of both the short and long fusions were substantially higher in cells grown with BCM, even with an intact boxA, suggesting that some Rho termination occurs upstream of the boxA. Moreover, expression of the long fusion was lower than that of the short fusion, even with an intact boxA, suggesting that Nus factors are unable to prevent all instances of Rho termination within the CRISPR array.
Our data indicate that CRISPR arrays in S. Typhimurium are protected from premature Rho termination by Nus factor association with RNAP via the BoxA sequences. However, this does not necessarily mean that CRISPR-Cas function is affected by anti-termination, since low levels of crRNA may be sufficient for Cas proteins to bind target DNA. We previously showed that the Cascade complex of Cas proteins in E. coli binds to DNA targets with as few as 5 bp between the cr-RNA and the target DNA. Consequently, the endogenous E. coli crRNAs direct Cascade binding to >100 chromosomal sites (21) . The E. coli CRISPR-Cas system is a type I-E system, similar to that in S. Typhimurium. Given this similarity, we hypothesized that S. Typhimurium Cascade would also bind chromosomal targets, and that we could measure the effectiveness of different CRISPR array spacers by measuring the degree to which those spacers direct Cascade binding to chromosomal sites. We used ChIP-seq to measure FLAG 3 -Cas5 association with the S. Typhimurium chromosome in cells expressing crRNAs from both CRISPR arrays. Note that we used a different constitutive promoter upstream of the CRISPR-II array to that described above for ChIP of SuhB, although the promoter was inserted at the same location (see Methods). As expected, we detected association of Cas5 with a large number (236) of chromosomal regions (Fig. 3A , Table  S1 ). These binding sites are associated with five strongly enriched sequence motifs that correspond to a PAM sequence and the seed regions of spacers 1, 2, 3, 4, and 11 from the CRISPR-I array (Fig. 3B ). These enriched motifs indicate that the optimal PAM in S. Typhimurium is AWG. We then attempted to identify the corresponding crRNA spacer for all 236 Cascade binding sites (see Methods). Thus, we were able to uniquely associate 152 binding sites with a single spacer from one of the two CRISPR arrays (Table S2 ). To test the quality of these spacer assignments, we repeated the ChIPseq experiment in a strain where the CRISPR-I array had been deleted. Consistent with our spacer assignments, Cas5 association decreased specifically at all DNA sites associated with spacers from the CRISPR-I array (Fig. S2) . By comparing the ChIP-seq data from wild-type and CRISPR-I deleted cells, we were able to unambiguously associate an additional 32 Cascade binding sites with a single spacer from one of the two CRISPR arrays (these binding sites had previously been associated with multiple possible spacers; Table S2 ).
We then measured FLAG 3 -Cas5 association with the S. Typhimurium chromosome in cells containing a single base pair substitution in the boxA upstream of CRISPR-II that is expected to abrogate NusB/E association (Fig. 1B) (18) (19) (20) . We observed no difference in Cas5 binding between the wildtype and mutant cells for sites associated with spacers from the CRISPR-I array, or sites associated with spacers 1-2 from the CRISPR-II array ( Fig. 4A ; Table S2 ). By contrast, mutation of the CRISPR-II boxA led to a large decrease in Cas5 binding to sites associated with spacers 9-23 from the CRISPR-II array ( Fig. 4A-B ; Table S2 ). This effect was reversed by addition of BCM to the boxA mutant cells ( Fig.  4C ; Table S2 ), indicating that reduced Cascade binding associated with spacers 9-23 of CRISPR-II is due to premature Rho termination of the array. Consistent with our reporter gene fusion data (Fig. 2B) , addition of BCM to cells with an intact boxA led to an increase in Cascade binding associated with spacers 9-23 of the CRISPR-II array ( Fig. S3; Table S2 ), supporting the notion that the BoxA prevents only a subset of premature Rho termination events.
We also measured FLAG 3 -Cas5 association with the S. Typhimurium chromosome in cells containing a single basepair substitution in the boxA upstream of the CRISPR-I array. Mutation of the CRISPR-I boxA had no impact on Cas5 binding to sites associated with spacers from the CRISPR-II array or spacers 1-5 from the CRISPR-II array ( Fig. 5A ; Table S2 ). By contrast, mutation of the CRISPR-I boxA led to a decrease in Cas5 binding to sites associated with spacers 9-17 from the CRISPR-I array (Fig. 5A) , with the magnitude of the effect increasing as a function of the position of the spacer in the array (Fig. 5B) . This effect was reversed by addition of BCM to the boxA mutant cells ( Fig. 5C ; Table S2 ), indicating that reduced Cascade binding using spacers 9-17 of CRISPR-I is due to premature Rho termination of the array. Unexpectedly, Cas5 binding associated with CRISPR-I spacers 18-23 was unaffected by the boxA mutation (Fig. 5B) , suggesting the existence of an additional promoter within spacer 16 or 17. Overall, the effect of mutating the CRISPR-I boxA was smaller than that of mutating the CRISPR-II boxA, suggesting that more RNAP can evade Rho termination at CRISPR-I. To confirm that the effects of mutating the boxA sequences are due to the inability to recruit the Nus factor complex, we measured FLAG 3 -Cas5 association with the S. Typhimurium chromosome in cells containing a defective Nus factor. We were unable to delete either nusB or suhB, suggesting that all Nus factors are essential in S. Typhimurium. Hence, we introduced a single base substitution into the chromosomal copy of the nusE gene, resulting in the N3H amino acid substitution. The equivalent change in the E. coli NusE leads to a defect in Nus factor complex function (18) . Note that mutation of nusE also resulted in a ∼147 kb deletion of the chromosome at an unlinked site. Mutation of nusE led to a decrease in Cascade binding to sites associated with spacers 9-23 from the CRISPR-II array and spacers 13-17 from the CRISPR-I array ( Fig. 6A ; Table S2 ). The effect of the nusE mutation on Cascade binding was smaller than that of the boxA mutations; however, the Nus factor complex is likely to retain partial function in the nusE mutant strain. To rule out the possibility that the chromosomal deletion in the nusE mutant strain was responsible for the effect on Cascade binding, we complemented the strain with plasmid-expressed wild-type NusE. Complementation led to a significant increase in the binding of Cas5 to sites associated with spacers 9-23 from the CRISPR-II array and spacers 13-17 from the CRISPR-I array ( Fig. 6B ; Table S2 ), consistent with a specific effect of mutating nusE. Similarly, addition of BCM to the nusE mutant cells resulted in a significant increase in the binding of Cas5 to sites associated with spacers 9-23 from the CRISPR-II array and spacers 13-17 from the CRISPR-I array ( Fig.  6C ; Table S2 ), indicating that reduced Cascade binding using spacers 9-23 of CRISPR-II and spacers 13-17 from the CRISPR-I array in the nusE mutant is due to premature Rho termination of the arrays. Based on the effects of mutating the boxA sequences and the effect of mutating nusE, we conclude that Nus factors prevent premature transcription termination of both S. Typhimurium CRISPR arrays, and that this has a direct impact on the ability of S. Typhimurium to use the majority of spacers in the CRISPR arrays. Given that Rho is found in 90% of bacterial species (22), and Nus factors are broadly conserved, we reasoned that species other than S. Typhimurium may use the Nus factor complex to facilitate expression of their CRISPR arrays. Hence, we performed a phylogenetic analysis of sequences associated with CRISPR arrays. Among sequences found between a cas2 gene and a downstream CRISPR array in 187 bacterial genera (each genus represented only once; see Methods for details of sequence selection), there was a strongly enriched sequence motif that is a striking match to the known boxA consensus ( Fig. 7 ; Table S3 ) (15, 18) . This motif was detected in 52 of the 187 genera examined, predominantly for genera in the Proteobacteria, Bacteroidetes and Cyanobacteria phyla. The boxA consensus is known to vary between species, diverging from the E. coli sequence with increasing evolutionary distance (15) . Hence, it is possible that boxA sequences were missed upstream of CRISPR arrays in bacterial genera that are less closely related to E. coli. Given that the Proteobacteria likely share a more recent common ancestor with phyla other than the Bacteroidetes and Cyanobacteria (23), we propose that boxA sequences upstream of CRISPR arrays either (i) evolved in a very early bacterial ancestor but were not detected in our analysis due to boxA sequence divergence, or (ii) evolved independently in multiple bacterial lineages. Regardless of its evolutionary history, it is clear that this phenomenon is distributed broadly across the bacterial kingdom.
Conclusions
In summary, we have identified a mechanism to prevent premature Rho-dependent transcription termination of CRISPR arrays that is conserved across a broad range of bacterial species. Our data indicate that anti-termination of CRISPR arrays by the Nus factor complex can be essential to allow use of all spacers, and thus highlight the importance of transcription anti-termination in the process of CRISPR biogenesis. While BoxA-mediated anti-termination is likely used to prevent premature termination of CRISPR array transcription in hundreds of species, many CRISPR arrays do not appear to be associated with a boxA. By contrast, Rho homologues are found in 90% of bacterial species (22) . An alternative strat- Fig. 7 . Widespread conservation of boxA sequences upstream of CRISPR arrays in diverse bacterial genera. Sequence motif found by MEME (30) to be significantly enriched upstream of 52 CRISPR arrays spread across the bacterial kingdom (from 187 tested; MEME E-value = 7.1e -69 ).
egy to circumvent the problems associated with Rho would be to avoid sequences in CRISPR arrays that can function as Rho loading sites. However, this would limit the sequence space for spacers that can be added to a CRISPR array, since any newly acquired spacer containing a strong Rho loading site would likely inactivate downstream spacers in the array. Similarly, limiting CRISPR array length would be an imperfect strategy to circumvent the problem of Rho termination, since this would limit the potential for acquisition of additional spacers in the array. Hence, we conclude that additional anti-termination mechanisms likely exist for bacterial CRISPR arrays.
Materials and Methods
Strains and plasmids. All strains, plasmids and oligonucleotides used in this study are listed in Tables S4 and  S5 , respectively. All strains are derivatives of Salmonella enterica subspecies enterica serovar Typhimurium 14028s (24) . Strains AMD678, AMD679, AMD684, AMD685, AMD698, AMD710, and AMD711 were generated using the FRUIT recombineering method (25) . To construct AMD678, oligonucleotides JW8576 and JW8577 were used to Nterminally FLAG 3 -tag cas5. Then, oligonucleotides JW8610 + JW8611 and JW8797 + JW8798 were used for insertion of a constitutive P KAB-TG promoter (26) in place of cas3, and upstream of the CRISPR-II array, respectively. AMD679, AMD684, AMD685, and AMD698 are derivatives of AMD678 and were generated using oligonucleotides (i) JW8913 and JW8914 to amplify thyA and replace the CRISPR-I array, (ii) JW8904-JW8907 for introduction of a CRISPR-I boxA mutation (C4A), (iii) JW8568-JW8571 for introduction of a CRISPR-II boxA mutation (C4A), and (iv) JW9441-JW9444 for introduction of a nusE mutation (N3H). AMD710 and AMD711 were derived from AMD678 and AMD685, respectively. They were constructed using oligonucleotides JW9355 + JW9356 to C-terminally TAP-tag suhB, with pVS030 (see below) as a PCR template. The constitutive P KAB-TG promoter (26) upstream of the CRISPR-II array was replaced by P J23119 -thyA, using oligonucleotides JW9627 + JW9628 and a strain containing thyA driven by the P J23119 promoter as a template for colony PCR. The plasmid pAMD239 was constructed by using oligonucleotides JW9674 and JW9675 to amplify nusE from wildtype 14028s. The resulting DNA fragment was cloned into pBAD24 (27) digested with HindIII and NheI. For the construction of pVS030, duplicate sets of TAP tags were colony PCR-amplified from a TAP-tagged strain of E. coli (28) using oligonucleotides JW6401 + JW6445 and JW6448 + JW6406. Oligonucleotides JW6446 + JW6447 were used to colony PCR-amplify thyA, as described previously (25) . All three DNA fragments were cloned into the pGEM-T plasmid (Promega) digested with SalI and NcoI. Plasmids pGB231, pGB237, pGB250, pGB256 were constructed by PCR-amplifying and cloning a truncated S. Tyhpimurium 14028s CRISPR-II array (to the 2nd or 11th spacer) and 292 bp of upstream sequence into the NsiI and NheI sites of the pJTW064 plasmid (29) with either a wildtype or mutant boxA sequence. A constitutive promoter was introduced upstream of the CRISPR-II sequence, creating a transcriptional fusion to lacZ. The following primers were used to PCR-amplify each CRISPR-II truncation: JW9381 + JW9383 (pGB231 and pGB237), JW9381 + JW9605 (pGB250 and pGB256). Fusions carrying boxA mutations were made by amplifying CRII from AMD678 template, which contains a boxA(C4A) mutation. ChIP-qPCR. Strains 14028s, AMD678, AMD710 and AMD711 were subcultured 1:100 in LB and grown to an OD 600 of 0.5-0.8. ChIP and input samples were prepared and analyzed as described previously (29) . For ChIP of β, 1 µl anti-β (RNA polymerase subunit) antibody was used.
For ChIP of SuhB-TAP, IgG Sepharose was used in place of Protein A Sepharose. Enrichment of ChIP samples was determined using quantitative real-time PCR with an ABI 7500 Fast instrument, as described previously (30) . Enrichment was calculated relative to a control region, within the sseJ gene (PCR-amplified using oligonucleotides JW4477 + JW4478), which is expected to be free of SuhB and RNA polymerase. Oligonucleotides used for qPCR amplification of the region within the CRISPR-I array were JW9305 + JW9306. Oligonucleotides used for qPCR amplification of the region surrounding the CRISPR-II boxA were JW9329 + JW9330. Oligonucleotides used for qPCR amplification of the region within rpsA were JW9660 + JW9661. Occupancy values represent background-subtracted enrichment relative to the control region. ChIP-seq. All ChIP-seq experiments were performed in duplicate. Cultures were inoculated 1:100 in LB with fresh overnight cultures of AMD678, AMD679, AMD684, and AMD685. Cultures of AMD678, AMD684 and AMD685 were split into two cultures at an OD 600 of 0.1, and bicyclomycin was added to one of the two cultures to a concentration of 20 µg/mL. At an OD 600 of 0.5-0.8, cells were processed for ChIP-seq of FLAG 3 -Cas5, following a protocol described previously (29) . For ChIP-seq using derivatives of the nusE mutant strain (AMD698), AMD698 containing either empty pBAD24 or pAMD239, was subcultured 1:100 in LB supplemented with 100 µg/mL ampicillin and 0.2% arabinose. AMD698 + pBAD24 cultures were split into two cultures at an OD 600 of 0.1. Bicyclomycin was added to one of the two cultures to a concentration of 20 µg/mL. At an OD 600 of 0.5-0.8, cells were processed for ChIP-seq of FLAG 3 -Cas5, following a protocol described previously (29) . ChIP-seq data analysis. Peak calling from ChIP-seq data was performed as previously described (31) . To assign specific crRNA spacer sequences to Cascade binding sites, we extracted 101 bp regions centered on each ChIP-seq peak for ChIP-seq data generated from AMD678. Overlapping regions were merged and the central position was used as a reference point for downstream analysis. We refer to this position as the "peak center". We then searched each ChIPseq peak region for a perfect match to positions 1-5 of each spacer from the CRISPR-I and CRISPR-II arrays, in addition to an immediately adjacent AAG or ATG sequence (the expected PAM sequence). Additionally, we searched each ChIP-seq peak region for a perfect match to positions 1-5 and positions 7-8 of each spacer from the CRISPR-I and CRISPR-II arrays. Spacers were only assigned to a ChIPseq peak if they had a unique match to a spacer sequence. This yielded 152 uniquely assigned peak-spacer combinations from the 236 ChIP-seq peaks. Enriched sequence motifs within the 236 peak regions ( Figure 3B ) were identified using MEME (v5.0.1, default parameters) (32).
To determine relative sequence read coverage at each ChIPseq peak center, we used Rockhopper (33) to determine relative sequence coverage at every genomic position on both strands for each ChIP-seq dataset. We then summed the relative sequence read coverage values on both strands for each peak center position to give peak center coverage values (Table S2) . To refine the assignment of spacers to ChIPseq peaks, we compared peak center coverage values for each peak in ChIP-seq datasets from AMD678 (CRISPR-I + ) and AMD679 (ΔCRISPR-I) strains. We calculated ratio of peak center coverage values in the first replicates of AMD679:AMD678 data, and repeated this for the second replicates, generating two ratio values. Based on ratio values assigned to peak centers that were already uniquely assigned to a spacer, we conservatively assumed that peak centers with both ratios <0.2 should be assigned a CRISPR-I spacer, whereas peak centers with both ratios >1.0 should be assigned a CRISPR-II spacer. Thus, we were able to uniquely assign spacers to an additional 32 peak centers that had previously been assigned multiple spacers. For example, if a peak center had previously been assigned two spacers from CRISPR-I and one spacer from CRISPR-II, we could uniquely assign the spacer from CRISPR-II of both rations were >1.0. Figures 3C-D, S2 , S3, S4A-C and S5A-C, values for peak center coverage were normalized in one replicate (two biological replicates were performed for all ChIPseq experiments) by summing the values at all peak centers to be analyzed (i.e. peak centers that could be uniquely assigned to a spacer) and multiplying values in the second replicate by a constant such that the summed values for each replicate were the same.
For data plotted in
β-galactosidase assays. S. Typhimurium 14028s containing pGB231, pGB237, pGB250, or pGB256 was grown at 37°C in LB medium to an OD 600 of 0.4-0.6. 810 µL of culture was pelleted and resuspended in 810 µL of Z buffer (0.06 M Na 2 HPO 4 , 0.04 M NaH 2 PO 4 , 0.01 M KCl, 0.001 M MgSO 4 ) + 50 mM β-mercaptoethanol + 0.001% SDS + 20 µL chloroform. Cells were lysed by brief vortexing. β-galactosidase reactions were started by adding 160 µL 2-Nitrophenyl β-D-galactopyranoside (4 mg/mL) and stopped by adding 400 µL of 1 M Na 2 CO 3 . The duration of the reaction and OD 420 readings were recorded. β-galactosidase activity was calculated as 1000 * (A 420 /(A 600 )(time [min])). Phylogenetic analysis of CRISPR array boxA conservation. Cas2 protein sequences were extracted from the PF09707 and PF09827 PFAM families (34, 35) . These sequences were then used to search a local collection of bacterial genome sequences using tBLASTn (36) . We then selected the 612 sequences with perfect matches to full-length Cas2 sequences. We further refined this set of sequences by arbitrarily selecting only one sequence per genus. We then extracted 300 bp downstream of each cas2 gene. We trimmed the 3' end of each sequence at the first instance of a 15 bp repeat, which is likely to be the beginning of a CRISPR array, since cas2 is often found upstream of a CRISPR array. Any sequences that lacked a 15 bp repeat, or were trimmed to <20 bp, were discarded. We used MEME (v5.0.1, default parameters) (32) to identify enriched sequence motifs in the remaining 187 sequences (Table S3) .
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